§ Funding Round
etherna immunotherapies raised $38.4M Series B venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Boehringer Ingelheim | — | — |
| Organization | — | |
Grand Decade | — | — |
LSP | — | — |
Novalis LifeSciences | — | — |
Omega Funds | — | — |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$104.4M
Top Valuation
-
etherna immunotherapies raised $38.4M in a Series B round.
The round was announced on 06/16/20.
